Kennedy Krieger and Johns Hopkins NeuroNEXT site supporting neurological clinical trials
Kennedy Krieger Institute - Johns Hopkins University NeuroNEXT Site
This program runs early-stage clinical trials to help find better treatments for children and adults with neurological conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hugo W. Moser Res Inst Kennedy Krieger NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11162521 on NIH RePORTER |
What this research studies
This NeuroNEXT site helps start and run early-phase trials for people with neurological disorders, using a central institutional review board and master trial agreements to speed study start-up. The team prioritizes including children as well as adults and brings patient and community voices into trial design and outreach. They also provide training and mentorship for new clinical trial investigators to expand capacity for high-quality studies. Overall, the site aims to make trials easier to join and results more generalizable for patients.
Who could benefit from this research
Good fit: Ideal candidates are children and adults with neurological conditions (for example acquired brain injury or autoimmune encephalitis) who are willing and able to participate in early-phase trials at the site.
Not a fit: People without neurological conditions or those unable to travel to the Baltimore site are unlikely to benefit directly from participation.
Why it matters
Potential benefit: If successful, this site can bring new treatments to patients faster and increase pediatric trial options with input from patients and communities.
How similar studies have performed: Previous NeuroNEXT work has completed early-phase neurology trials on time and sped trial start-up through a central IRB and master agreements.
Where this research is happening
Baltimore, United States
- Hugo W. Moser Res Inst Kennedy Krieger — Baltimore, United States (Active)
Researchers
- Principal investigator: Augustine, Erika — Hugo W. Moser Res Inst Kennedy Krieger
- Study coordinator: Augustine, Erika
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.